99 related articles for article (PubMed ID: 19101395)
21. The urine sediment as a biomarker of kidney disease.
Perazella MA
Am J Kidney Dis; 2015 Nov; 66(5):748-55. PubMed ID: 25943719
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic correction and early detection of tubulointerstitial fibrosis prevent disease progression in chronic kidney disease.
Futrakul N; Siriviriyakul P; Futrakul P
Ren Fail; 2004 Mar; 26(2):199-200. PubMed ID: 15287207
[No Abstract] [Full Text] [Related]
23. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients.
van Timmeren MM; Vaidya VS; van Ree RM; Oterdoom LH; de Vries AP; Gans RO; van Goor H; Stegeman CA; Bonventre JV; Bakker SJ
Transplantation; 2007 Dec; 84(12):1625-30. PubMed ID: 18165774
[TBL] [Abstract][Full Text] [Related]
24. Antiproteinuric effect of losartan in patients with chronic renal diseases.
Locatelli F
Nephrol Dial Transplant; 1997 Oct; 12(10):2204-6. PubMed ID: 9351098
[No Abstract] [Full Text] [Related]
25. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
Agarwal R
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
[TBL] [Abstract][Full Text] [Related]
26. Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy.
Appenroth D; Beutinger R; Lupp A; Fleck C
Exp Toxicol Pathol; 2003 Jun; 54(5-6):359-66. PubMed ID: 12877346
[TBL] [Abstract][Full Text] [Related]
27. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K
Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973
[TBL] [Abstract][Full Text] [Related]
28. Novel kidney injury biomarkers.
Adler S
J Ren Nutr; 2010 Sep; 20(5 Suppl):S15-8. PubMed ID: 20797563
[TBL] [Abstract][Full Text] [Related]
29. Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
Kjeldsen SE; Lyle PA; Kizer JR; Oparil S; Høieggen A; Os I
Vasc Health Risk Manag; 2007; 3(3):299-305. PubMed ID: 17703637
[TBL] [Abstract][Full Text] [Related]
30. KIM-1 expression in kidney allograft biopsies: Improving the gold standard.
Abulezz S
Kidney Int; 2008 Mar; 73(5):522-3. PubMed ID: 18274540
[TBL] [Abstract][Full Text] [Related]
31. Tubular kidney injury molecule-1 (KIM-1) in human renal disease.
van Timmeren MM; van den Heuvel MC; Bailly V; Bakker SJ; van Goor H; Stegeman CA
J Pathol; 2007 Jun; 212(2):209-17. PubMed ID: 17471468
[TBL] [Abstract][Full Text] [Related]
32. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
33. Time to abandon microalbuminuria?
Ruggenenti P; Remuzzi G
Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239
[TBL] [Abstract][Full Text] [Related]
34. Which is a better treatment for hypertensive patients with diabetes: a combination of losartan and hydrochlorothiazide or a maximum dose of losartan?
Nishimura H; Shintani M; Maeda K; Otoshi K; Fukuda M; Okuda J; Nishi S; Ohashi S; Kato S; Baba Y;
Clin Exp Hypertens; 2013; 35(8):582-8. PubMed ID: 23496265
[TBL] [Abstract][Full Text] [Related]
35. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
[TBL] [Abstract][Full Text] [Related]
36. Long-term antihypertensive efficacy of losartan/hydrochlorothiazide combination therapy on home blood pressure control.
Miyagawa S; Yamada H; Matsubara H
Clin Exp Hypertens; 2012; 34(6):439-46. PubMed ID: 22471874
[TBL] [Abstract][Full Text] [Related]
37. Aliskiren combined with losartan in diabetes and nephropathy.
Lindner T
N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
[No Abstract] [Full Text] [Related]
38. Proteinuria and tubulointerstitial injury: the causative factors for the progression of renal diseases.
Matsuo S; Morita Y; Maruyama S; Manchang L; Yuzawa Y
Contrib Nephrol; 2003; 139():20-31. PubMed ID: 12854316
[No Abstract] [Full Text] [Related]
39. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
[TBL] [Abstract][Full Text] [Related]
40. Aliskiren combined with losartan in diabetes and nephropathy.
Anderson S; Komers R
N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
